Acute coronary syndromes: optimizing the therapeutic options

Acute coronary syndromes: optimizing the therapeutic options.

guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American college of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2001; 38: 294–5. [9] Califf RM, Abdelmeguid AE, Kuntz RE et al. Myonecrosis after revascular...

Pathogenesis of the acute coronary syndromes and therapeutic implications.

Atherosclerosis is characterized by the thickening and obstruction of the arterial lumen and thrombosis associated with vulnerable disrupted plaques seems to be responsible for the accelerated process of clinical syndrome presentation. Strategies to promote plaque stabilization and reduce thrombus burden have been one of the major targets of recent times. Modification of diet and lifestyle has ...

Prognostic value of C-Reactive Protein in Acute Coronary Syndromes

Introduction: Coronary artery disease (CAD) is among the most common, serious, chronic and life- threatening illnesses in the world. CAD represents a spectrum of conditions, with acute myocardial infarction at one end of it and silent ischemia at the other. There is growing evidence on importance of prognosis of C- reactive protein (CPR) in unstable angina and this protein is a maker of an adve...

Risk Stratification and Therapeutic Decision Making in Acute Coronary Syndromes

with an acute STEMI, the optimal treatment is usually clear-proceed to PCI immediately. The situation is less clear with unstable angina and NSTEMI's, a heterogeneous group of acute coronary syndromes with a wide spectrum of risk for death and cardiac ischemic events. Prognostication of risk in these patients is critical as it can dictate optimal therapy and location of treatment (outpatient vs...

Risk stratification and therapeutic decision making in acute coronary syndromes.